Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics ...

In the 10-K report, Amneal Pharmaceuticals disclosed its summarized consolidated cash flows for the years ended December 31, ...

Industry leaders warn that potential US tariffs on Indian pharmaceutical exports could increase drug costs for American ...

Amneal Pharmaceuticals, Inc. has recently released its 10-K report, providing a comprehensive overview of its business ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of ...

Reports Q4 revenue $190.6M vs. $131.65M last year. Nikhil Lalwani, President and CEO of ANI stated, “We’re thrilled to report another year of ...

Amneal Pharmaceuticals' Q4 sales rose 18% to $730.52M, surpassing estimates, while adjusted EPS missed. The company forecasts ...